Giuseppe Gargiulo
Overview
Explore the profile of Giuseppe Gargiulo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
2452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mancusi C, Basile C, Spaccarotella C, Gargiulo G, Fucile I, Paolillo S, et al.
High Blood Press Cardiovasc Prev
. 2024 Mar;
31(2):127-140.
PMID: 38489152
Heart failure (HF) with preserved ejection fraction (HFpEF) is a prevalent global condition affecting approximately 50% of the HF population. With the aging of the worldwide population, its incidence and...
12.
Di Serafino L, Turturo M, Larosa C, Scalamogna M, Cirillo P, Vito Alessandro A, et al.
J Invasive Cardiol
. 2024 Feb;
36(5).
PMID: 38422529
Objectives: Patent hemostasis (PH) is essential for preventing radial artery occlusion (RAO) after trans-radial procedures; however, it remains unclear how it should be obtained. The aim of this multicenter randomized...
13.
Gargiulo G, Cirillo P, Sperandeo L, Forzano I, Castiello D, Florimonte D, et al.
Int J Cardiol Heart Vasc
. 2024 Feb;
50:101344.
PMID: 38419600
Background: There are limited data to assess pharmacodynamic (PD) profiles of patients with STEMI undergoing primary percutaneous coronary intervention (PCI) and receiving cangrelor after pretreatment with ticagrelor. Methods: The PharmacOdynaMic...
14.
Manzi L, Sperandeo L, Forzano I, Castiello D, Florimonte D, Paolillo R, et al.
Diagnostics (Basel)
. 2024 Jan;
14(2).
PMID: 38248013
Heart failure (HF) has a global prevalence of 1-2%, and the incidence around the world is growing. The prevalence increases with age, from around 1% for those aged <55 years...
15.
Gragnano F, Capolongo A, Micari A, Costa F, Garcia-Ruiz V, de Sio V, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202105
The antithrombotic management of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) poses numerous challenges. Triple antithrombotic therapy (TAT), which combines dual antiplatelet therapy (DAPT) with oral anticoagulation...
16.
Gargiulo G, Giacoppo D
EuroIntervention
. 2024 Jan;
20(1):21-23.
PMID: 38165108
No abstract available.
17.
Cattabriga G, Giordani G, Gargiulo G, Cavaliere V
Front Physiol
. 2023 Sep;
14:1249205.
PMID: 37693001
Biogenic amines are crucial signaling molecules that modulate various physiological life functions both in vertebrates and invertebrates. In humans, these neurotransmitters influence the innate and adaptive immunity systems. In this...
18.
Ueki Y, Haner J, Losdat S, Gargiulo G, Shibutani H, Bar S, et al.
Thromb Haemost
. 2023 Aug;
124(6):517-527.
PMID: 37595625
Objective: The effect of the PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor alirocumab on platelet aggregation among patients with acute myocardial infarction (AMI) remains unknown. We aimed to explore the...
19.
Piccolo R, Leone A, Simonetti F, Avvedimento M, Angellotti D, Manzi L, et al.
Catheter Cardiovasc Interv
. 2023 Jun;
102(2):212-220.
PMID: 37337462
Background: Limited data are available on the risk of periprocedural myocardial infarction (MI) in patients undergoing complex versus noncomplex percutaneous coronary intervention (PCI). Methods: We assessed the risk of periprocedural...
20.
Canonico M, Piccolo R, Avvedimento M, Leone A, Esposito S, Franzone A, et al.
J Cardiovasc Dev Dis
. 2023 Apr;
10(4).
PMID: 37103043
Patients with peripheral artery disease (PAD) are at an increased risk of major adverse cardiovascular events, and those with disease in the lower extremities are at risk of major adverse...